Vasculitis

SAN DIEGO — Pregnant patients with vasculitis demonstrate an increased frequency of spontaneous abortion and preterm delivery vs. healthy controls, according to data presented at ACR Convergence 2023.

SAN DIEGO — Trimethoprim sulfamethoxazole prophylaxis halves serious infection risk in patients with granulomatosis with polyangiitis receiving B-cell depletion with rituximab, according to data presented at ACR Convergence 2023.

SAN DIEGO — The future of ANCA-associated vasculitis management appears promising, as upcoming therapies will likely address current unmet needs, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

Patients with COVID-19 demonstrate a 43% increased risk for new-onset autoimmune diseases in the 3 to 15 months following acute infection, according to data published in Clinical Rheumatology.

Highlights of the upcoming 2023 Congress of Clinical Rheumatology-West include a talk on what the rheumatology field will look like in a decade, according to David A. McLain, MD, symposium director for the meeting.

Children with Cogan’s syndrome should undergo thorough evaluations upon presentation, including screenings for autoimmune and infectious diseases, as well as echocardiography and brain MRI, according to data.

The advancement of retinal therapies offers promise and hopefully no peril to those willing to push the boundaries of medical science into new indications.

MRI and PET scans are viable alternatives to ultrasound for cranial arteries in patients with suspected giant cell arteritis, according to a 2023 update of EULAR’s recommendations for imaging in large vessel vasculitis.

DESTIN, Fla. — Despite advances in biologic therapies, “excess steroid use” remains a mainstay of treatment for patients with ANCA-associated vasculitis, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.